C-Advantage Program

The Corrective Advantage Program is the first FDA non-invasive and non-surgical treatment Program in the United States and is led by Brent Concolino President of ROCK Institute. This technology has over 300 FDA approved Studies and the Program combines our proprietary therapy technique as well as the technology from Storz Medical in Switzerland. Treatments are clinically proven and tested for any and all tendonopathys, Arthritis, shin splints, Ligament damage, Capsular Contracture, Neuropathy, and much more… The program starts with a three treatment plan at $600 and is logged into a case study for future accuracy of sports injuries. Call to see if you are a candidate and we will give a 15 minute free phone consultation.